Alan Green joins the UK Investor Magazine Podcast as we explore the key influences on the FTSE 100 including vaccines, Brexit, Sterling and Rishi Sunak's latest spending plans. We also discuss in detail Power Metal Resources (POW), Venture Life Group (VLG) and Itaconix (ITX).

FTSE 100: The influences of vaccines and Brexit on London's leading index

Alan Green joins the UK Investor Magazine Podcast to dissect the factors driving the small caps markets in the United States and the UK. We explore factors such as vaccines, Brexit and natural resources. In keeping with prior Podcasts, we pay attention to three UK equities in Bidstack (BIDS), Destiny Pharma (DEST) and RA International (RAI).

Market dynamics of UK and US small cap growth shares

The UK Investor Magazine Podcast is joined by Alan Green for a run down of the dramatic moves in markets this week and exploration of scenarios going into the end of 2020. The Biden Presidential victory has been overshadowed by news from Pfizer had a breakthrough in the fight against COVID-19 with a vaccine demonstrating 90% effectiveness. We look at the sharp rally in markets and question the sustainability going forward. We discuss Novacyt (NCYT), Synairgen (SNG), Avacta (AVCT), Blue Prism (PRSM) and Capita (CPI).

The new vaccine chapter for value stocks and COVID-19 shares

Mode Banking Executive Chairman Jonathan Rowland joins the UK Investor Magazine Podcast to discuss recent progress at Mode and their plans for the future. Mode Group Holdings (LON:MODE) has recently listed on the LSE Standard List raising £7.5m to fund the growth of their Digital Asset Banking App that harnesses Open Banking systems.

Interview with Mode Banking Executive Chairman, Jonathan Rowland

This Podcast was recorded as we await the results of key states in the US and we briefly discuss the factors at play in the market including the huge sigh of relief in US stocks and the shift of attention to global stimulus. We also explore Blencowe Resources (BRES), Keras Resources (KRS) and Cadence Minerals (KDNC).

The signs potentially signalling an equity rally

Nadeem Sarwar, Founder of Phlo, experienced the frustrations and challenges with obtaining prescription medication. He was fed up going to the pharmacy where there was either no stock or long waiting times. Nadeem then founded Phlo, a patient first online pharmacy integrating with NHS Accredited systems to provide same-day, real-time delivery that fits around a patient's life. 29 million patients in England are on an NHS repeat prescription with a market value of £15.6 billion. With an ageing population, the market opportunity is substantial. Additionally, COVID-19 has greatly increased demand for telemedicine and digital pharmacy services. With 43% of adults in England on at least one prescription, Phlo is helping put patients back in control of their medication – anytime, anywhere. You can visit Phlo's crowdfunding <a href="https://www.crowdcube.com/companies/phlo-technologies-ltd/pitches/b3n8zZ" rel="noopener noreferrer" target="_blank">Crowdcube page here</a>

Phlo: Investing In The Pharmacy Of The Future

The UK Investor Magazine Podcast is joined by Alan Green for a run down of the biggest themes in markets as we look at Gfinity (GFIN), AB Dynamics (ABDP) and Itaconix (ITX). If you missed the UK Investor Magazine Virtual Conference, you can <a href="https://ukinvestormagazine.lpages.co/uk-investor-magazine-virtual-conference-20th-october/" rel="noopener noreferrer" target="_blank">view the presentations here. </a>

Looking past the US elections to underlying value in equities 

The UK Investor Magazine Podcast is joined by Tickr to discuss the latest trends in impact investing and how the investment app has navigated COVID-19.

Impact Investing resilience and sustainability trends through COVID-19  with Tickr

Justin Urquhart Stewart joined us for the UK Investor Magazine Virtual Investor Conference 20th October to discuss key investment themes including US elections, Brexit, the UK economy and investing regionally.